Dallas, TX - The Publisher of Daily OTC Stocks Newsletter (http://www.otcpicks.com/hotpicks.htm) and Free Red Hot Stock Picks presents the following penny stocks to watch today: Futureworld Energy Inc. (OTC: FWDG), Tytan Holdings Inc. (OTC: TYTN) and Intellect Neurosciences Inc. (OTCBB: ILNS).
FUTUREWORLD ENERGY INCORPORATED (OTC: FWDG) "Up 12.00% in morning trading"
FutureWorld Energy, Inc., a Delaware corporation, is a U.S. Diversified Energy Holding Company, listed on the Over the Counter exchange, which was formed to capitalize on the burgeoning markets in renewable and alternative energy technologies globally. FutureWorld Energy, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of renewable and alternative energy technologies globally. Through established relationships with universities, research centers and government agencies, we strive to identify technologies on the leading edge of innovation that would contribute immensely to the global energy needs while protecting the future for our children and theirs.
TYTAN HOLDINGS INCORPORATED (OTC: TYTN) "Up 44.44% in morning trading"
Tytan Holdings, Inc. is a holding corporation with strategic focus in acquisition of agricultural equipment manufactures and exploration of environmental technologies.
INTELLECT NEUROSCIENCES (OTCBB: ILNS) "Up 8.28% in morning trading"
Intellect Neurosciences, Inc., a biopharmaceutical company, engages in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and other disorders of the central nervous system. The company's product pipeline includes small molecules, monoclonal antibodies, and vaccines that address unmet needs in Alzheimer's disease and other indications, including ataxia, Parkinson's disease, Huntington's disease, diabetes, stroke, myelodysplastic syndromes, motor neuron disease (ALS and Lou Gehrig's disease), and radiation injury. Its lead drug candidate, OXIGON, is a chemically synthesized form of a small, potent, dual mode of action, naturally occurring molecule with potential as a disease-modifying agent for Alzheimer's disease and other therapeutic indications. OXIGON has completed human Phase Ia clinical trials. Intellect Neurosciences also develops immunotherapies (monoclonal antibodies and vaccines) to prevent or arrest the progression of Alzheimer's disease, while avoiding the risk of adverse reactions. The company also has various proprietary immunotherapy platforms, such as ANTISENILIN, RECALL-VAX, and BETA-VAX with patented drug candidates for both passive and active immunization against Alzheimer's disease. ANTISENILIN is a passive monoclonal antibody platform, and RECALL-VAX and BETA-VAX are platform technologies for vaccination. The company was founded in 2005 and is headquartered in New York, New York.
The stocks presented above are available in OTCPicks.com's Free Daily Email Newsletter. For daily penny stock alerts go to http://www.otcpicks.com/hotpicks.htm
Get the latest updates via Twitter at www.twitter.com/otcpicks or through Facebook - www.facebook.com/otcpicks.
Disclosure: OTCPicks has been compensated ten thousand dollars from a third party (Hoboken Street Associates) for FWDG advertising and promotional services.
